NCT04601584 2024-03-06GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALLAO GENERIUMPhase 1/2 Unknown36 enrolled
NCT06075212 2023-10-10Immune Reconstitution After Allo-HSCT and BlinatumomabSichuan UniversityUnknown20 enrolled
NCT00315419 2010-04-21Identifying Characteristics of Bone Marrow Failure SyndromesOffice of Rare Diseases (ORD)Unknown450 enrolled
NCT00801580 2009-09-15My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid LeukemiaUniversity of BolognaPhase 2 Unknown3 enrolled